MARKET

QDEL

QDEL

Quidel
NASDAQ
93.03
+0.84
+0.91%
Opening 12:55 12/07 EST
OPEN
93.04
PREV CLOSE
92.19
HIGH
94.19
LOW
92.62
VOLUME
130.43K
TURNOVER
7.82M
52 WEEK HIGH
180.06
52 WEEK LOW
66.88
MARKET CAP
6.14B
P/E (TTM)
5.54
1D
5D
1M
3M
1Y
5Y
4 Analysts Have This to Say About QuidelOrtho
Benzinga · 5h ago
RBC Initiates QuidelOrtho at Outperform With $125 Price Target, Sees Potential for Market Share Gains, Sales Acceleration Beyond 2024
RBC Initiates QuidelOrtho at Outperform With $125 Price Target, Sees Potential for Market Share Gains, Sales Acceleration Beyond 2024
MT Newswires · 9h ago
QuidelOrtho to Host Investor Day on December 13, 2022
SAN DIEGO, November 30, 2022--QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho"), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that it wil...
Business Wire · 6d ago
Will the Demand for QuidelOrtho Corporation (QDEL)’s Products Increase in Near Term?
Alger Capital, an investment management company, released its “Alger Small Cap Focus Fund” third quarter investor letter. A copy of the same can be downloaded here. In the third quarter, the fund outperformed the Russell 2000 Growth Index. Consumer discret...
Insider Monkey · 11/08 16:05
--UBS Adjusts QuidelOrtho Price Target to $93 From $86, Maintains Neutral Rating
--UBS Adjusts QuidelOrtho Price Target to $93 From $86, Maintains Neutral Rating
MT Newswires · 11/04 12:41
JP Morgan Maintains Neutral on QuidelOrtho, Lowers Price Target to $93
Benzinga · 11/03 15:09
QuidelOrtho Q3 net income negatively impacted by decline in high margin COVID revenue
Seekingalpha · 11/02 22:14
Quidel Q3 EPS $1.85 Beats $0.74 Estimate, Sales $783.80M Beat $719.60M Estimate
Benzinga · 11/02 20:45
More
About QDEL
QuidelOrtho Corporation is a vitro diagnostics company. The Company is engaged in the development and manufacturing of advanced technologies in diagnostic testing. Its product portfolio covers a range of point-of-care tests for infectious diseases, critical cardiac health and autoimmune biomarkers, and a range of clinical and at-home products to detect COVID-19. The Company’s capabilities include immunoassay development, automated manufacturing, monoclonal antibody characterization and development, molecular assay development, lab-based in vitro diagnostics, blood bank solutions and transfusion pre-screening. Its product categories include visually-read lateral flow, direct fluorescent antibodies, micro-titer production, fluorescent immunoassay products, molecular diagnostic products including its flagship Savanna, immunodiagnostics and integrated testing systems, pre-transfusion testing, immunodiagnostic donor screening systems and services, and ortho care services and informatics.

Webull offers kinds of Quidelortho Corp stock information, including NASDAQ:QDEL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, QDEL stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading QDEL stock methods without spending real money on the virtual paper trading platform.